Abstract
The Australian market for interventional cardiology devices was valued at over
$100 million in 2007.
This market is comprised of coronary stents, percutaneous transluminal
coronary angioplasty (PTCA) balloon catheters, PTCA guidewires, diagnostic
catheters, PTCA guiding catheters, and introducer sheaths.
|